Vall d´Hebron Institute of Oncology
(VHIO) – Barcelona, Spain
Vall d’Hebron Institute of Oncology (VHIO) (http://www.vhio.net/) is a private non-profit organization committed to translational research in oncology. The Institute has a broad expertise in carrying out clinical trials with pathway-targeted inhibitors and studies for the development of novel diagnostic/ prognostic tools and translational research. VHIO is part of the Vall d’Hebron University Hospital complex, and performs translational and early clinical research providing a link between basic and clinical research. The VHIO works in close collaboration with the Medical Oncology Department of the Vall d’Hebron Hospital through an outstanding Clinical Research Program integrated by more than 30 staff medical oncologists, in addition to research fellows, clinical study co-ordinators, clinical study assistants, research nurses and clinical pharmacists. In 2014, the institution conducted 246 clinical trials in solid tumors and 83 phase I clinical trials with novel targeted agents, and a total of 771 patients participated in therapeutic trials (303 in phase I trials).